MaioRegen (Coming Soon)




Lesions of the joint surface are a very common clinical challenge, frequently diagnosed also in young people. If untreated, they may degenerate into chronic, disabling conditions that can be addressed only by an invasive approach.

In most cases, an articular cartilage damage implies a simultaneous suffering of the sub-chondral bone structure. To guarantee the successful restoration of an healthy and functional joint, we should go "to the core of the problem".

MaioRegen is a new therapeutic concept, inspired by nature and shaped by state-of-the-art Nanotechnologies. It promotes and guides an effective bone and cartilage regeneration, thus restoring the natural joint physiology.

MaioRegen is indicated in all cases where it is necessary to restore osteo-cartilaginous connective tissue in the joints, in particular in the treatment of:

- osteo-chondral lesions of traumatic, post-traumatic, degenerative origin or due to osteochondritis dissecans; III-IV grade lesions (Outerbridge classification);

- focal, single or multiple lesions.

- MaioRegen should not be used in patients with advanced osteoarthritic conditions, immune system disorders, neoplastic diseases, infectious diseases, obesity (BMI > 30) or above 60 years of age.

Click Here to Read More
Maioregen